
1. j biol chem. 2003 aug 15;278(33):30711-8. epub 2003 jun 7.

1hepatitis c virus ns5a protein modulates c-jun n-terminal kinase through
interaction tumor necrosis factor receptor-associated factor 2.

park kj(1), choi sh, choi dh, park jm, yie sw, lee sy, hwang sb.

author information: 
(1)ilsong institute life science, hallym university, chuncheon 200-702, korea.

the nonstructural 5a (ns5a) protein hepatitis c virus (hcv) a
phosphoprotein possessing various functions. previously reported the
hcv ns5a protein interacts tumor necrosis factor (tnf) receptor-associated
factor (traf) domain traf2 (park, k.-j., choi, s.-h., lee, s. y., hwang, s.
b., lai, m. m. c. (2002) j. biol. chem. 277, 13122-13128). tnf-alpha-
and traf2-mediated nuclear factor-kappab (nf-kappab) activations inhibited
by ns5a-traf2 interaction. traf2 required activation both
nf-kappab c-jun n-terminal kinase (jnk), investigated hcv ns5a protein for
its potential capacity modulate traf2-mediated jnk activity. using vitro
kinase assay, found ns5a protein synergistically activated both
tnf-alpha- traf2-mediated jnk human embryonic kidney 293t cells.
furthermore, synergism ns5a-mediated jnk activation inhibited by
dominant-negative form mek kinase 1. vivo binding data show ns5a
does inhibit interaction tnf receptor-associated death domain and
traf2 protein, indicating ns5a traf2 may form ternary complex tnf
receptor-associated death domain. results indicate hcv ns5a protein
modulates tnf signaling host cells may play role hcv
pathogenesis.

doi: 10.1074/jbc.m209623200 
pmid: 12796506  [indexed medline]

